A 14-Month Study On The Effects Of CP-945,598 For The Prevention Of Weight Regain In Obese Patients

NCT00483171 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

699

Enrollment

INDUSTRY

Sponsor class

Stopped See termination reason in detailed description.

Conditions

Obesity

Interventions

DRUG: CP-945,598
BEHAVIORAL: Non-pharmacological weight loss program (NPP)
BEHAVIORAL: Low Calorie Diet

Sponsor

Pfizer